Cargando…

Mining the Genome for Therapeutic Targets

Current pharmacological options for type 2 diabetes do not cure the disease. Despite the availability of multiple drug classes that modulate glycemia effectively and minimize long-term complications, these agents do not reverse pathogenesis, and in practice they are not selected to correct the molec...

Descripción completa

Detalles Bibliográficos
Autor principal: Florez, Jose C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482091/
https://www.ncbi.nlm.nih.gov/pubmed/28603140
http://dx.doi.org/10.2337/dbi16-0069